Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Kriengkauykiat

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|November 19, 2003
Systemic antifungal therapy: new options, new challengesAnnie Wong-Beringer, Jane Kriengkauykiat
Clinical Epidemiology|July 14, 2011
Epidemiology and treatment approaches in management of invasive fungal infectionsJane Kriengkauykiat, James I Ito, Sanjeet S Dadwal
Antimicrobial Agents and Chemotherapy|January 28, 2005
Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosaJane Kriengkauykiat, Edith Porter, Olga Lomovskaya, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2020
The impact of an automated antibiotic stewardship intervention for the management of Staphylococcus aureus bacteraemia utilizing the electronic health recordAmy L Brotherton, Saira Rab, Sheetal Kandiah, et al.
Pharmacotherapy|January 12, 2013
Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective reviewSamantha Davies-Vorbrodt, James I Ito, Bernard R Tegtmeier, et al.
Leukemia & Lymphoma|July 16, 2010
Approaches to the early treatment of invasive fungal infectionJames I Ito, Jane Kriengkauykiat, Sanjeet S Dadwal, et al.
Journal of Global Health Reports|May 14, 2023
Identifying the priority infection prevention and control gaps contributing to neonatal healthcare-associated infections in low-and middle-income countries: results from a modified Delphi processDaiva Yee, Hanako Osuka, Jamine Weiss, et al.
Pharmacotherapy|June 26, 2008
Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosisPaul M Beringer, Jane Kriengkauykiat, Xiyun Zhang, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosisPaul Beringer, Kitty My Tu Huynh, Jane Kriengkauykiat, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 17, 2019
Cost analysis of ganciclovir and foscarnet in recipients of allogeneic hematopoietic cell transplant with cytomegalovirus viremiaJason Chen, Justine Abella Ross, Bernard Tegtmeier, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|November 19, 2003
Systemic antifungal therapy: new options, new challengesAnnie Wong-Beringer, Jane Kriengkauykiat
Clinical Epidemiology|July 14, 2011
Epidemiology and treatment approaches in management of invasive fungal infectionsJane Kriengkauykiat, James I Ito, Sanjeet S Dadwal
Antimicrobial Agents and Chemotherapy|January 28, 2005
Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosaJane Kriengkauykiat, Edith Porter, Olga Lomovskaya, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2020
The impact of an automated antibiotic stewardship intervention for the management of Staphylococcus aureus bacteraemia utilizing the electronic health recordAmy L Brotherton, Saira Rab, Sheetal Kandiah, et al.
Pharmacotherapy|January 12, 2013
Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective reviewSamantha Davies-Vorbrodt, James I Ito, Bernard R Tegtmeier, et al.
Leukemia & Lymphoma|July 16, 2010
Approaches to the early treatment of invasive fungal infectionJames I Ito, Jane Kriengkauykiat, Sanjeet S Dadwal, et al.
Journal of Global Health Reports|May 14, 2023
Identifying the priority infection prevention and control gaps contributing to neonatal healthcare-associated infections in low-and middle-income countries: results from a modified Delphi processDaiva Yee, Hanako Osuka, Jamine Weiss, et al.
Pharmacotherapy|June 26, 2008
Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosisPaul M Beringer, Jane Kriengkauykiat, Xiyun Zhang, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosisPaul Beringer, Kitty My Tu Huynh, Jane Kriengkauykiat, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 17, 2019
Cost analysis of ganciclovir and foscarnet in recipients of allogeneic hematopoietic cell transplant with cytomegalovirus viremiaJason Chen, Justine Abella Ross, Bernard Tegtmeier, et al.
Pageof 1